Klaria Pharma Holding AB (publ.) 6FN.F Stock
Klaria Pharma Holding AB (publ.) Price Chart
Klaria Pharma Holding AB (publ.) 6FN.F Financial and Trading Overview
| Klaria Pharma Holding AB (publ.) stock price | 0.02 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.03 EUR |
| Bid | 0.02 EUR x N/A |
| Ask | 0.05 EUR x N/A |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.02 - 0.41 EUR |
| Volume | 29.56K EUR |
| Avg. Volume | 527 EUR |
| Market Cap | 3.64M EUR |
| Beta (5Y Monthly) | 0.364796 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6FN.F Valuation Measures
| Enterprise Value | 3.71M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.012520868 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Klaria Pharma Holding AB (publ.) Stock Price History
| Beta (5Y Monthly) | 0.364796 |
| 52-Week Change | -93.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.41 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.04 EUR |
| 200-Day Moving Average | 0.12 EUR |
6FN.F Share Statistics
| Avg. Volume (3 month) | 527 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 106.5M |
| Float | 97.82M |
| Short Ratio | N/A |
| % Held by Insiders | 10.73% |
| % Held by Institutions | 9.75% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 100.00% |
| EBITDA Margin | -241.92% |
Management Effectiveness
| Return on Assets (ttm) | -23.67% |
| Return on Equity (ttm) | -68.47% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 5.87M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.756 |
| Book Value Per Share (mrq) | 2.396 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Klaria Pharma Holding AB (publ.)
| Country | Germany |
| State | N/A |
| City | Uppsala |
| Address | Virdings Allé 2 |
| ZIP | 754 50 |
| Phone | 46 84 46 42 99 |
| Website | https://www.klaria.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.
Q&A For Klaria Pharma Holding AB (publ.) Stock
What is a current 6FN.F stock price?
Klaria Pharma Holding AB (publ.) 6FN.F stock price today per share is 0.02 EUR.
How to purchase Klaria Pharma Holding AB (publ.) stock?
You can buy 6FN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Klaria Pharma Holding AB (publ.)?
The stock symbol or ticker of Klaria Pharma Holding AB (publ.) is 6FN.F.
Which industry does the Klaria Pharma Holding AB (publ.) company belong to?
The Klaria Pharma Holding AB (publ.) industry is Drug Manufacturers-Specialty & Generic.
How many shares does Klaria Pharma Holding AB (publ.) have in circulation?
The max supply of Klaria Pharma Holding AB (publ.) shares is 106.5M.
What is Klaria Pharma Holding AB (publ.) Price to Earnings Ratio (PE Ratio)?
Klaria Pharma Holding AB (publ.) PE Ratio is now.
What was Klaria Pharma Holding AB (publ.) earnings per share over the trailing 12 months (TTM)?
Klaria Pharma Holding AB (publ.) EPS is -0.04 EUR over the trailing 12 months.
Which sector does the Klaria Pharma Holding AB (publ.) company belong to?
The Klaria Pharma Holding AB (publ.) sector is Healthcare.